Unusual regulation of expression of the herpes simplex virus DNA polymerase gene.
During herpes simplex virus infection, expression of the viral DNA polymerase (pol) gene is regulated temporally as an early (beta) gene and is additionally down-regulated at late times at the level of translation (D. R. Yager, A. I. Marcy, and D. M. Coen, J. Virol. 64:2217-2225, 1990). To examine the role of viral DNA synthesis in pol regulation, we studied pol expression during infections in which viral DNA synthesis was blocked, either by using drugs that inhibit Pol or ribonucleotide reductase or by using viral mutants with lesions in either the pol or a primase-helicase subunit gene. Under any of these conditions, the level of cytoplasmic pol mRNA was reduced. This reduction was first seen at approximately the time DNA synthesis begins and, when normalized to levels of other early mRNAs, became as great as 20-fold late in infection. The reduction was also observed in the absence of the adjacent origin of replication, oriL. Thus, although pol mRNA accumulated as expected for an early gene in terms of temporal regulation, it behaved more like that of a late (gamma) gene in its response to DNA synthesis inhibition. Surprisingly, despite the marked decrease in pol mRNA in the absence of DNA synthesis, the accumulation of Pol polypeptide was unaffected. This was accompanied by loss of the normal down-regulation of translation of pol mRNA at late times. We suggest a model to explain these findings.
Wobbe
K K
KK
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.
Digard
P
P
Staknis
D
D
Coen
D M
DM
D000818:Animals; D016590:Aphidicolin / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004259:DNA-Directed DNA Polymerase / Q000096:biosynthesis / Q000235:genetics*; D015774:Ganciclovir / Q000494:pharmacology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D015967:Gene Expression Regulation, Viral / Q000187:drug effects; D015751:Genes, pol; D006918:Hydroxyurea / Q000494:pharmacology; D007700:Kinetics; D010746:Phosphonoacetic Acid / Q000494:pharmacology; D014176:Protein Biosynthesis / Q000187:drug effects; D012333:RNA, Messenger / Q000096:biosynthesis / Q000378:metabolism; D012367:RNA, Viral / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D018139:Simplexvirus / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics*; D013937:Thymidine Kinase / Q000096:biosynthesis; D014158:Transcription, Genetic / Q000187:drug effects; D014709:Vero Cells
D012333:RNA, Messenger; D012367:RNA, Viral; D016590:Aphidicolin; D013937:Thymidine Kinase; D004259:DNA-Directed DNA Polymerase; D010746:Phosphonoacetic Acid; D015774:Ganciclovir; D006918:Hydroxyurea